ADC Therapeutics (ADCT) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

ADC Therapeutics Price Target Maintained With a $10.00/Share by Guggenheim
Dow JonesDec 12 10:40 ET · Ratings
ADC Therapeutics Stock Plunges 36% Amid Zynlonta Data Release
Seeking AlphaDec 11 16:27 ET
H.C. Wainwright Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Maintains Target Price $8
Moomoo NewsDec 11 10:31 ET · Ratings
Promising Efficacy in LOTIS-7 Trial Boosts Buy Rating for ADC Therapeutics
TipRanksDec 11 10:25 ET · Ratings
Express News | ADC Therapeutics SA - No Dose-Limiting Toxicities or High-Grade Crs/Icans Observed
ReutersDec 11 07:30 ET
ADC Therapeutics Announces Positive Initial Data From LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination With Bispecific Antibody in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
PR NewswireDec 11 07:30 ET

Comments

Bang mi

Dec 12 10:10

Over traded

Reminder to my self. I have lost half of the profit. Keep discipline and stick to the rules

Share Your Profit/Loss

5

2

Jaguar8

Dec 11 21:35

🕒Watchlist THURSDAY 12/11. NFA. Trade the Chart, not emotions.

Please take note of the following acronyms
NFA = not financial advice
RTH = regular trading hours
AH = after hours
LTB = left to borrow
CTB = cost to borrow
*I removed $AmpliTech Group (AMPG.US)$ because it just announced direct offering of $2M valued $1.6/shares. Now there are offerings where market defies it and continues to rally. We shall see tomorrow
$Nuburu (BURU.US)$ PR AH 12/11: Resolved compliance issue. Up AH. Low float. CTB...

114

38

6

Jaguar8

Dec 11 06:30

NEWS

$ADC Therapeutics (ADCT.US)$
ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
Wednesday, 11th December at 7:30 am
ZYNLONTA in combination with glofitamab demonstrated clinically meaningful benefit with 94% best ORR and 72% CR rate
Safety data show no dose-limiting toxicities (DLTs), no high-grade cytokine release syndrome (CRS) or high-g...

2

Jaguar8

Dec 9 06:57

NEWS

$ADC Therapeutics (ADCT.US)$
ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma
ADC Therapeutics announced updated data from two clinical trials evaluating ZYNLONTA®. In the first trial, ZYNLONTA combined with rituximab for relapsed/refractory follicular lymphoma showed a 97.4% overall response rate and 76.9% complete response rate, with 12-m...

This_Guy

Dec 8 16:00

What Is Day Trading?

Day trading is a fast paced trading strategy where traders aim to profit from short term price movements within a single trading day. Unlike swing trading, which involves holding positions for days or weeks, day traders close all trades before the market closes to avoid overnight risks such as earnings announcements or geopolitical events that could impact stock prices.
This strategy relies heavily on technical analysis, with traders using charts, patterns, and indicators li...

5

ADCT ADC Therapeutics

Trade Overview

Capital Trend

News

Comments